Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer

NCT04843319 is registered in ClinicalTrials.gov with Veru Inc. as lead sponsor.

NCT NCT04843319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04843319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer
Lead sponsor
Veru Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
June 9, 2021
Completion date
January 19, 2023
Enrollment
24 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate adenocarcinoma